37th International Conference on Biomedical & Cancer Research
  • Follow

Accepted Abstracts

Survival and Predictors of Mortality among Breast Cancer Patients in Northwest Ethiopia

Mulu Tiruneh*
Debre Tabor University, Ethiopia.

Citation: Tiruneh M (2023) Survival and Predictors of Mortality among Breast Cancer Patients in Northwest Ethiopia. SciTech Biomed-Cancer 2023.

Received: November 09, 2022         Accepted: November 11, 2022         Published: November 11, 2022

Abstract

Background: Breast cancer is the most common malignant tumor and the leading causeofcancer death in over 100 countries. Despite the high burden of difficulty, the survival status and the predictors for mortality are not yet determined in Ethiopia. Studies related to this area are scarce. Therefore, we aimed to estimate the survival status and predictors of mortality among breast cancer patients in Northwest Ethiopia.
Methods: A retrospective cohort study design was carried out from September 2015 to August 2020 among 482 women who had breast cancer in Northwest Ethiopia. A systematic Sampling technique was employed to select the required representative sample. The Cox regression model was used to identify the predictors of mortality among breast cancer patients.
Results: For this study, 482 participants had followed for 8824 person-months total analysis timeor at-risk time. In our findings, the overall survival of breast cancer patients at the end of two and five years was 54.24% and 25.8%, respectively. In the multivariable Cox regression model, age,stageofBC, menopausal status, and surgicaltherapyweresignificant predictors of death.
Conclusion: The overall survival after two years was 54.24%, and after five years was 25.8%. This result is lower than the recently published report and indicates that in LMIC, especially in rural cancer centers, the infrastructure and resources for routine screening mammography are often unavailable. Therefore, there is a need to promote early diagnosis of BCat each level of health-care delivery point.